Preventive Maintenance and Repair Service Agreement for Emulate Zoe CM1 and CM2 culture modules

The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Drug Evaluation and Research (CDER) requirement for a preventive maintenance and repair service agreement for Emulate Zoe CM1 and CM2 culture modules. The FDA is seeking small business sources to determine the availability and capability of small businesses capable of providing the required supplies. The scope of work includes one-year maintenance contract, one-time preventative maintenance service, and one year of coverage for Emulate machinery. The maintenance services must ensure proper functioning of equipment compatible with lung and blood-milk barriers' MPS chips for Emulate's Zoe Culture Module. Some key requirements include: • One scheduled on-site planned preventive maintenance visit per year per instrument • Unlimited on-site corrective maintenance and repairs • Unlimited technical support (via phone and email) on software and hardware related issues • Maintenance coverage must include all compatible MPS chips and equipment • Maintenance services must ensure proper calibration and functionality of all equipment components The FDA encourages any comments and/or suggestions from interested parties regarding the specifications.